Zurich Cantonal Bank’s Seres Therapeutics MCRB Stock Holding History

Zurich Cantonal Bank’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,530	Closed	-$72.8K	–	2766
2023 Q3	$72.8K	Hold	1,530	–	–	﹤0.01%	2496
2023 Q2	$147K	Buy	1,530 +329	+27%	+$35.8K	﹤0.01%	2124
2023 Q1	$136K	Buy	1,201 +337	+39%	+$36.5K	﹤0.01%	2103
2022 Q4	$96.7K	Buy	864 +331	+62%	+$44.4K	﹤0.01%	2295
2022 Q3	$68K	Hold	533	–	–	﹤0.01%	2465
2022 Q2	$37K	Hold	533	–	–	﹤0.01%	2675
2022 Q1	$76K	Buy	533 +188	+54%	+$28.9K	﹤0.01%	2392
2021 Q4	$57K	Hold	345	–	–	﹤0.01%	2699
2021 Q3	$48K	Hold	345	–	–	﹤0.01%	2624
2021 Q2	$164K	Sell	345 -88	-20%	-$37.1K	﹤0.01%	1939
2021 Q1	$178K	Hold	433	–	–	﹤0.01%	1848
2020 Q4	$212K	Buy	+433	New	+$254K	﹤0.01%	1804
2019 Q2	–	Sell	-54	Closed	-$7K	–	2620
2019 Q1	$7K	Hold	54	–	–	﹤0.01%	2541
2018 Q4	$5K	Hold	54	–	–	﹤0.01%	2576
2018 Q3	$8K	Hold	54	–	–	﹤0.01%	2559
2018 Q2	$9K	Hold	54	–	–	﹤0.01%	2501
2018 Q1	$8K	Hold	54	–	–	﹤0.01%	2508
2017 Q4	$11K	Hold	54	–	–	﹤0.01%	2486
2017 Q3	$17K	Hold	54	–	–	﹤0.01%	2309
2017 Q2	$12K	Hold	54	–	–	﹤0.01%	2390
2017 Q1	$12K	Hold	54	–	–	﹤0.01%	2444
2016 Q4	$11K	Buy	+54	New	+$11.8K	﹤0.01%	2424

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zurich Cantonal Bank's MCRB Position: Q4 2023 in Review

Zurich Cantonal Bank sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 1,530 shares — an estimated $72.8K sold.

Zurich Cantonal Bank first reported a position in MCRB in Q4 2016 and held it in 22 quarters. The position peaked at $212K in Q4 2020. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

Zurich Cantonal Bank reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 1,530 Seres Therapeutics shares in Q4 2023, an estimated $72.8K.
Zurich Cantonal Bank first reported a position in Seres Therapeutics in Q4 2016 and held it in 22 quarters.
Zurich Cantonal Bank's Seres Therapeutics position peaked at $212K in Q4 2020.
102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.